Type 2 diabetes mellitus is a metabolic disorder characterized by peripheral insulin resistance and a failure of beta cells to compensate, leading to hyperglycemia. While once considered an adult pathology, it is increasing in prevalence in children. Risk factors for children are similar to those in adults: ethnicity, family history, obesity, and sedentary lifestyle. However, presentation and management differ from adults with the disorder. Children with diabetes (of any kind) are at an increased risk of many complications of the disease. Early recognition, screening, and treatment of children with type 2 diabetes mellitus are important for prevention of long-term complications from the disease.
Hyperglycemia results when there is a relative lack of insulin compared to glucose in the blood. In type 2 diabetes mellitus, insulin resistance first leads to increased insulin production by the beta cells of the pancreas. When the beta cells are unable to produce enough insulin to maintain euglycemia, hyperglycemia results. Hyperglycemia has damaging effects to multiple organs, including kidneys, eyes, heart, and nerves. Further, hyperglycemia puts children at risk for other electrolyte disturbances.
Comparatively, type 1 diabetes mellitus is characterized by autoimmune destruction of beta cells in the pancreas leading to a lack of insulin production.
Type 1 diabetes remains the most prevalent form of diabetes in children. However, type 2 diabetes mellitus is estimated to occur in one in three (20% to 33%) of new diagnoses of diabetes in children today. The rate of type 2 diabetes mellitus in children continues to rise even as the obesity rates have plateaued in these age groups. Risk factors include high-risk ethnicity (African American, Hispanic, Native Americans, Pacific Islanders, Asian Americans), a positive first-degree relative with the disorder, obesity, low birth weight, mother with gestational diabetes, and female sex. It is more likely to be diagnosed during adolescence when insulin resistance is common due to multiple factors including hormonal changes. 
Obesity leads to peripheral insulin resistance, which in turn leads to hyperglycemia as discussed. Independent of obesity, certain ethnicities have higher risks of insulin resistance and beta cell dysfunction. Hyperglycemia leads to an osmotic diuresis (polyuria), which increases thirst (polydipsia). This diuresis causes moderate to severe dehydration. Prolonged hyperglycemia can produce two distinct emergent states in type 2 diabetes mellitus in children:
Diabetic ketoacidosis: much more common in children with type 2 diabetes mellitus compared to adults. Lack of insulin inhibits the body's ability to use glucose for energy and reverts to breaking down fat for energy. This leads to ketosis, acidosis, and electrolyte abnormalities and may lead to coma and death.
Hyperglycemic Hyperosmolar State (HHS): characterized by hypertonicity, extreme hyperglycemia (> 600 mg/dl), and severe dehydration. The profound hyperglycemia results in continued osmotic diuresis and intravascular depletion.
Children with type 2 diabetes mellitus most often present during asymptomatic screening.
Children may have the typical symptoms of polyuria, polydipsia, polyphagia, and weight loss. Children with type 2 diabetes mellitus are more likely than adults with the disorder to present in DKA (5% to 13%), especially if they are of ethnic minority descent. Adolescents with type 2 diabetes mellitus may also present in Hyperosmolar Hyperglycemic State (HHS).
Physical exam findings can include acanthosis nigricans (dark, velvety rash present in the axillae and neck). The American Diabetes Association recommends screening children at 10 years old or at the start of puberty in children who are obese (> 95th percentile BMI for age) or are overweight (BMI > 85th percentile for age or > 120% ideal body weight) and have two risk factors. These factors can be positive family history, high-risk ethnicity, signs of insulin resistance (polycystic ovary syndrome (PCOS), acanthosis, symptoms), or history of maternal gestational diabetes mellitus.
If the diagnosis between type 1 and type 2 diabetes mellitus is not clear, helpful labs include fasting insulin or c peptide (both usually high or normal in type 2 diabetes mellitus, low in type 1 diabetes mellitus ), and autoantibodies for type 1 diabetes mellitus.
The American Academy of Pediatrics recommends lifestyle modifications and Metformin as the first line therapy. Lifestyle changes include moderate to vigorous exercise for 60 minutes per day, limiting screen time to less than two hours per day, and a dietary referral.
Metformin and/or insulin should be started at diagnosis. Metformin is first line and available as a liquid. Start at 500 mg/day and increase by 500 mg every one to two weeks to a maximum of 2000 mg twice a day. The gradual increase of the medication and taking it with food helps to prevent gastrointestinal side effects.
Insulin should be started for patients who are ketotic or in diabetic ketoacidosis (DKA), have a random blood glucose > 250 mg/dl, an A1C > 9.0%, or in whom the diagnosis of type 1 vs. type 2 is not clear. May use a basal/bolus regimen like in type 1 diabetes mellitus, but typically type 2 diabetes mellitus patients require higher doses (2 unit/kg/day - 3 unit/kg/day). Insulin should be initiated and managed by pediatric endocrinologists. Insulin takers have a risk of hypoglycemia; therefore frequent monitoring is required.
Home glucose monitoring is recommended for those who take insulin, have not met glucose control goals, are changing medications, or are sick.
A1C test goals vary by association. American Diabetes Association and the American Academy of Pediatrics list an A1C test goal of < 7%, while the American Association of Clinical Endocrinologists places the goal at < 6.5%.
Complications of type 2 diabetes in children are similar to that of adults. Complications tend to occur after a person has had the disease for many years. Those who are diagnosed in childhood have the disease for longer periods of time. Therefore, strict control and management of blood glucose are crucial to help prevent these complications. All people with diabetes should have regular dilated eye exams (to examine for diabetic retinopathy), urine microalbumin screening at appropriate intervals (evaluated for renal involvement), hyperlipidemia screens/treatment, hypertension screening/treatment, and regular monitoring.
Type 2 diabetes in children is best managed by an interprofessional team that includes a pediatrician, primary care provider, diabetic nurse, endocrinologist, and relevant specialists. The American Academy of Pediatrics recommends lifestyle modifications and metformin as first-line therapy. Lifestyle changes include moderate to vigorous exercise for 60 minutes per day, limiting screen time to less than two hours per day, and a dietary referral.
It is vital to ensure that these children are also evaluated by the ophthalmologist, nephrologist, cardiologist and dental surgeon. Complications of type 2 diabetes in children are similar to that of adults. Complications tend to occur after a person has had the disease for many years. Those who are diagnosed in childhood have the disease for longer periods of time. Therefore, strict control and management of blood glucose are crucial to help prevent these complications. All people with diabetes should have regular dilated eye exams (to examine for diabetic retinopathy), urine microalbumin screening at appropriate intervals (evaluated for renal involvement), hyperlipidemia screens/treatment, hypertension screening/treatment, and regular monitoring.
|||Chen Y,Wang T,Liu X,Shankar RR, Prevalence of Type 1 and Type 2 Diabetes among US Pediatric Population in the MarketScan Multi-State Medicaid Database, 2002-2016. Pediatric diabetes. 2019 Mar 12; [PubMed PMID: 30861241]|
|||Winhusen T,Theobald J,Kaelber DC,Lewis D, Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: Electronic health record findings. Addiction (Abingdon, England). 2019 Mar 9; [PubMed PMID: 30851217]|
|||Crawford R,Sims ED,Wang KW,Youssef M,Nadarajah A,Rivas A,Banfield L,Thabane L,Samaan MC, Traditional knowledge-based lifestyle interventions in the prevention of obesity and type 2 diabetes in Indigenous children in Canada: a systematic review protocol. Systematic reviews. 2019 Mar 6; [PubMed PMID: 30841917]|
|||Hernández-Montoya D,Soriano-Flores A,Esparza-Aguilar M,Benjet C,Llanes-Díaz N, Variation in incidence of type 2 diabetes mellitus: time series of Mexican adolescents. Annals of epidemiology. 2019 Feb; [PubMed PMID: 30528324]|
|||Jensen ET,Dabelea D, Type 2 Diabetes in Youth: New Lessons from the SEARCH Study. Current diabetes reports. 2018 May 8; [PubMed PMID: 29737424]|
|||Pelham JH,Hanks L,Aslibekyan S,Dowla S,Ashraf AP, Higher hemoglobin A1C and atherogenic lipoprotein profiles in children and adolescents with type 2 diabetes mellitus. Journal of clinical [PubMed PMID: 30547005]|
|||Caprio S,Pierpont B,Kursawe R, The [PubMed PMID: 29596053]|
|||Lee AM,Fermin CR,Filipp SL,Gurka MJ,DeBoer MD, Examining trends in prediabetes and its relationship with the metabolic syndrome in US adolescents, 1999-2014. Acta diabetologica. 2017 Apr; [PubMed PMID: 28070750]|
|||Hagman E,Danielsson P,Brandt L,Ekbom A,Marcus C, Association between impaired fasting glycaemia in pediatric obesity and type 2 diabetes in young adulthood. Nutrition [PubMed PMID: 27548712]|
|||Oester IM,Kloppenborg JT,Olsen BS,Johannesen J, Type 2 diabetes mellitus in Danish children and adolescents in 2014. Pediatric diabetes. 2016 Aug; [PubMed PMID: 26111830]|
|||Bhatt M,Nahari A,Wang PW,Kearsley E,Falzone N,Chen S,Fu E,Jeyakumar Y,Zukowski J,Banfield L,Thabane L,Samaan MC, The quality of clinical practice guidelines for management of pediatric type 2 diabetes mellitus: a systematic review using the AGREE II instrument. Systematic reviews. 2018 Nov 15; [PubMed PMID: 30442196]|
|||Albert Pérez E,Mateu Olivares V,Martínez-Espinosa RM,Molina Vila MD,Reig García-Galbis M, New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT. Nutrients. 2018 Jul 6; [PubMed PMID: 29986479]|
|||Cha E,Paul S,Braxter BJ,Umpierrez G,Faulkner MS, Dietary Behaviors and Glucose Metabolism in Young Adults at Risk for Type 2 Diabetes. The Diabetes educator. 2018 Apr; [PubMed PMID: 29495910]|
|||Vaughan EM,Johnston CA,Cardenas VJ,Moreno JP,Foreyt JP, Integrating CHWs as Part of the Team Leading Diabetes Group Visits: A Randomized Controlled Feasibility Study. The Diabetes educator. 2017 Dec; [PubMed PMID: 29047326]|
|||Zurita-Cruz JN,Manuel-Apolinar L,Arellano-Flores ML,Gutierrez-Gonzalez A,Najera-Ahumada AG,Cisneros-González N, Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health and quality of life outcomes. 2018 May 15; [PubMed PMID: 29764429]|